Daewoong Co., Ltd. (003090.KS)
KRW 20450.0
(0.74%)
KRW 20450.0
(0.74%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1815.1 Billion KRW | 6.94% |
| 2022 | 1697.33 Billion KRW | 12.3% |
| 2021 | 1511.37 Billion KRW | 11.51% |
| 2020 | 1355.33 Billion KRW | -0.76% |
| 2019 | 1365.67 Billion KRW | 10.92% |
| 2018 | 1231.17 Billion KRW | 9.53% |
| 2017 | 1124.07 Billion KRW | 10.75% |
| 2016 | 1015.01 Billion KRW | 1.84% |
| 2015 | 996.64 Billion KRW | 11.48% |
| 2014 | 893.97 Billion KRW | 5.98% |
| 2013 | 843.53 Billion KRW | 175.53% |
| 2012 | 306.15 Billion KRW | 13.12% |
| 2011 | 270.64 Billion KRW | -59.66% |
| 2010 | 670.82 Billion KRW | -12.5% |
| 2009 | 766.64 Billion KRW | 10.31% |
| 2008 | 695.01 Billion KRW | 14.45% |
| 2007 | 607.24 Billion KRW | 21.24% |
| 2006 | 500.88 Billion KRW | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 473.29 Billion KRW | 6.63% |
| 2024 Q1 | 443.86 Billion KRW | -0.71% |
| 2023 Q2 | 469.42 Billion KRW | 7.7% |
| 2023 Q4 | 447.04 Billion KRW | -3.14% |
| 2023 FY | 1815.1 Billion KRW | 6.94% |
| 2023 Q3 | 461.51 Billion KRW | -1.68% |
| 2023 Q1 | 435.85 Billion KRW | -2.04% |
| 2022 Q2 | 422.06 Billion KRW | 6.17% |
| 2022 FY | 1697.33 Billion KRW | 12.3% |
| 2022 Q4 | 444.92 Billion KRW | 2.8% |
| 2022 Q3 | 432.8 Billion KRW | 2.54% |
| 2022 Q1 | 397.54 Billion KRW | -1.86% |
| 2021 Q3 | 376.27 Billion KRW | -1.37% |
| 2021 FY | 1511.37 Billion KRW | 11.51% |
| 2021 Q1 | 348.53 Billion KRW | 1.06% |
| 2021 Q2 | 381.49 Billion KRW | 9.46% |
| 2021 Q4 | 405.06 Billion KRW | 7.65% |
| 2020 FY | 1355.33 Billion KRW | -0.76% |
| 2020 Q4 | 344.88 Billion KRW | -2.34% |
| 2020 Q1 | 328.29 Billion KRW | -6.81% |
| 2020 Q2 | 329.01 Billion KRW | 0.22% |
| 2020 Q3 | 353.14 Billion KRW | 7.34% |
| 2019 FY | 1365.67 Billion KRW | 10.92% |
| 2019 Q4 | 352.28 Billion KRW | 5.36% |
| 2019 Q1 | 318.58 Billion KRW | -2.3% |
| 2019 Q3 | 334.37 Billion KRW | -7.23% |
| 2019 Q2 | 360.43 Billion KRW | 13.14% |
| 2018 FY | 1231.17 Billion KRW | 9.53% |
| 2018 Q1 | 288.11 Billion KRW | 2.53% |
| 2018 Q2 | 308.41 Billion KRW | 7.05% |
| 2018 Q4 | 326.1 Billion KRW | 5.68% |
| 2018 Q3 | 308.59 Billion KRW | 0.06% |
| 2017 Q4 | 280.99 Billion KRW | -4.44% |
| 2017 Q2 | 286.18 Billion KRW | 8.88% |
| 2017 FY | 1124.07 Billion KRW | 10.75% |
| 2017 Q3 | 294.04 Billion KRW | 2.74% |
| 2017 Q1 | 262.84 Billion KRW | -2.89% |
| 2016 FY | 1015.01 Billion KRW | 1.84% |
| 2016 Q2 | 246.26 Billion KRW | 1.92% |
| 2016 Q4 | 270.67 Billion KRW | 5.53% |
| 2016 Q1 | 241.63 Billion KRW | -4.36% |
| 2016 Q3 | 256.49 Billion KRW | 4.16% |
| 2015 Q4 | 252.65 Billion KRW | -3.59% |
| 2015 Q2 | 240.93 Billion KRW | -0.05% |
| 2015 FY | 996.64 Billion KRW | 11.48% |
| 2015 Q1 | 241.05 Billion KRW | 2.83% |
| 2015 Q3 | 262.06 Billion KRW | 8.77% |
| 2014 Q4 | 234.41 Billion KRW | 2.52% |
| 2014 FY | 893.97 Billion KRW | 5.98% |
| 2014 Q3 | 228.65 Billion KRW | 3.25% |
| 2014 Q2 | 221.45 Billion KRW | 5.73% |
| 2014 Q1 | 209.45 Billion KRW | -4.91% |
| 2013 FY | 843.53 Billion KRW | 175.53% |
| 2013 Q2 | 203.89 Billion KRW | -0.18% |
| 2013 Q3 | 215.01 Billion KRW | 5.45% |
| 2013 Q4 | 220.25 Billion KRW | 2.44% |
| 2013 Q1 | 204.26 Billion KRW | 163.92% |
| 2012 Q1 | 10.02 Billion KRW | 0.0% |
| 2012 FY | 306.15 Billion KRW | 13.12% |
| 2012 Q4 | -319.55 Billion KRW | -253.91% |
| 2012 Q3 | 207.62 Billion KRW | -4.7% |
| 2012 Q2 | 217.85 Billion KRW | 2073.11% |
| 2011 Q1 | 10.22 Billion KRW | 0.0% |
| 2011 FY | 270.64 Billion KRW | -59.66% |
| 2011 Q4 | - KRW | -100.0% |
| 2011 Q3 | 10.62 Billion KRW | 0.88% |
| 2011 Q2 | 10.53 Billion KRW | 3.05% |
| 2010 Q1 | - KRW | -100.0% |
| 2010 FY | 670.82 Billion KRW | -12.5% |
| 2010 Q2 | 9.47 Billion KRW | 0.0% |
| 2010 Q3 | 7.82 Billion KRW | -17.41% |
| 2009 Q3 | 6.82 Billion KRW | -24.3% |
| 2009 FY | 766.64 Billion KRW | 10.31% |
| 2009 Q1 | - KRW | -100.0% |
| 2009 Q2 | 9.01 Billion KRW | 0.0% |
| 2009 Q4 | 9.55 Billion KRW | 39.92% |
| 2008 Q4 | 7.71 Billion KRW | -8.75% |
| 2008 Q1 | - KRW | -100.0% |
| 2008 Q3 | 8.45 Billion KRW | 2.18% |
| 2008 Q2 | 8.27 Billion KRW | 0.0% |
| 2008 FY | 695.01 Billion KRW | 14.45% |
| 2007 Q2 | 6.9 Billion KRW | 0.0% |
| 2007 Q4 | 7.47 Billion KRW | -6.63% |
| 2007 FY | 607.24 Billion KRW | 21.24% |
| 2007 Q3 | 8 Billion KRW | 16.02% |
| 2006 FY | 500.88 Billion KRW | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| PharmGen Science, Inc. | 166.77 Billion KRW | -988.33% |
| Wooridul Huebrain Limited | 55.75 Billion KRW | -3155.787% |